Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven K Libutti

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Surgery|December 8, 2010
Endocrine surgery specialty training: opportunities for growthSteven K Libutti
Cancer Gene Therapy|July 10, 2019
Recording 25 years of progress in Cancer Gene TherapySteven K Libutti
Nature Reviews. Endocrinology|June 5, 2013
Therapy: Blockade of IGF-1R-not effective in neuroendocrine tumoursSteven K Libutti
Surgery|November 20, 2016
Editorial: Treatment decision making in the era of genetic testing and molecular diagnosticsSteven K Libutti
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Understanding the role of gender in the incidence of thyroid cancerSteven K Libutti
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Do angiogenesis inhibitors perform a physiologic gatekeeper role in cancer prevention?Steven K Libutti
Surgery|November 21, 2016
Of mice and men(in) and what I have learned from bothSteven K Libutti
The Journal of Clinical Endocrinology and Metabolism|December 7, 2013
Evolving paradigm for managing small nonfunctional incidentally discovered pancreatic neuroendocrine tumorsSteven K Libutti
Surgery|October 27, 2019
Early-stage pancreatic neuroendocrine tumors (PNETs): Patience is a virtueSteven K Libutti
Clinical Advances in Hematology & Oncology : H&O|October 18, 2005
Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptorsAnita Tandle, Steven K Libutti
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Surgery|December 8, 2010
Endocrine surgery specialty training: opportunities for growthSteven K Libutti
Cancer Gene Therapy|July 10, 2019
Recording 25 years of progress in Cancer Gene TherapySteven K Libutti
Nature Reviews. Endocrinology|June 5, 2013
Therapy: Blockade of IGF-1R-not effective in neuroendocrine tumoursSteven K Libutti
Surgery|November 20, 2016
Editorial: Treatment decision making in the era of genetic testing and molecular diagnosticsSteven K Libutti
Cancer Journal (Sudbury, Mass.)|June 23, 2005
Understanding the role of gender in the incidence of thyroid cancerSteven K Libutti
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Do angiogenesis inhibitors perform a physiologic gatekeeper role in cancer prevention?Steven K Libutti
Surgery|November 21, 2016
Of mice and men(in) and what I have learned from bothSteven K Libutti
The Journal of Clinical Endocrinology and Metabolism|December 7, 2013
Evolving paradigm for managing small nonfunctional incidentally discovered pancreatic neuroendocrine tumorsSteven K Libutti
Surgery|October 27, 2019
Early-stage pancreatic neuroendocrine tumors (PNETs): Patience is a virtueSteven K Libutti
Clinical Advances in Hematology & Oncology : H&O|October 18, 2005
Antiangiogenic therapy: targeting vascular endothelial growth factor and its receptorsAnita Tandle, Steven K Libutti
Pageof 23